ENDRA Life Sciences
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $211 | $0 |
Gross Profit | -39 | -32 | -45 | |
EBITDA | -1,556 | -1,193 | -990 | -4,250 |
EBIT | -1,595 | -1,225 | -1,036 | -4,296 |
Net Income | -1,595 | -1,225 | -1,036 | -4,149 |
Net Change In Cash | 0 | 0 | 211 | 0 |
Free Cash Flow | -1,164 | -1,113 | -1,310 | -1,515 |
Cash | 794 | 1,808 | 2,064 | 3,229 |
Basic Shares | 761 | 717 | 557 | 534 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -206 | -275 | -234 | -224 |
EBITDA | -10,770 | -9,784 | -12,944 | -11,006 |
EBIT | -10,817 | -10,060 | -13,179 | -11,231 |
Net Income | -11,507 | -10,060 | -13,179 | -11,231 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,416 | -9,582 | -12,971 | -11,167 |
Cash | 3,229 | 2,833 | 4,889 | 9,461 |
Basic Shares | 1,122 | 1,707 | 1,930 | 2,046 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$2.10 |
2025-06-30 | -$1.71 |
2025-03-31 | -$7.72 |
2024-12-31 | $25.20 |
